Stockscreener 앱 받기
11.01
8.25%
-0.99
시간 외 거래:
10.95
-0.06
-0.54%
전일 마감가:
$12.00
열려 있는:
$11.37
하루 거래량:
642.09K
Relative Volume:
1.50
시가총액:
$367.77M
수익:
$2.07M
순이익/손실:
$-47.68M
주가수익비율:
-3.9043
EPS:
-2.82
순현금흐름:
$-31.31M
1주 성능:
-16.27%
1개월 성능:
-20.04%
6개월 성능:
+25.54%
1년 성능:
+118.89%
1일 변동 폭
$10.57
$11.61
1주일 범위
$10.57
$13.39
52주 변동 폭
$4.26
$16.97
Delcath Systems Inc Stock (DCTH) Company Profile
명칭
Delcath Systems Inc
전화
(518) 743-8892
주소
566 QUEENSBURY AVENUE, QUEENSBURY, NY
DCTH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DCTH
Delcath Systems Inc
|
11.01 | 367.77M | 2.07M | -47.68M | -31.31M | -2.82 |
|
ABT
Abbott Laboratories
|
124.44 | 215.82B | 41.95B | 13.40B | 6.35B | 7.65 |
|
SYK
Stryker Corp
|
345.80 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
BSX
Boston Scientific Corp
|
89.70 | 132.67B | 16.75B | 1.85B | 2.37B | 1.25 |
|
MDT
Medtronic Plc
|
82.88 | 106.28B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
69.36 | 40.63B | 5.72B | 4.17B | 259.90M | 6.97 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-28 | 개시 | Craig Hallum | Buy |
| 2024-05-14 | 개시 | Stephens | Overweight |
| 2022-07-26 | 재개 | Canaccord Genuity | Buy |
| 2021-12-10 | 개시 | H.C. Wainwright | Buy |
| 2021-03-09 | 개시 | Canaccord Genuity | Buy |
| 2021-01-05 | 개시 | BTIG Research | Buy |
| 2020-06-01 | 개시 | Laidlaw | Buy |
모두보기
Delcath Systems Inc 주식(DCTH)의 최신 뉴스
How To Trade (DCTH) - news.stocktradersdaily.com
Pheochromocytoma Treatment Market Size in 7MM is expected - openPR.com
Hospitals Experience FOMO In Adopting Delcath’s PHP Treatment (NASDAQ:DCTH) - Seeking Alpha
Delcath Systems, Inc. (NASDAQ:DCTH) Is Expected To Breakeven In The Near Future - simplywall.st
5,470 Shares in Delcath Systems, Inc. (NASDAQ:DCTH) Acquired by Quantbot Technologies LP - Defense World
Delcath Systems (NASDAQ:DCTH) and West Pharmaceutical Services (NYSE:WST) Critical Survey - Defense World
Beta Bionics appoints new board member from Delcath Systems By Investing.com - Investing.com South Africa
Beta Bionics appoints new board member from Delcath Systems - Investing.com India
Beta Bionics Announces Board Appointment of Gerard Michel - The Manila Times
Jim Cramer Blesses Delcath Systems (DCTH): ‘You’re Not Early, But It’s a Win’ - MSN
Jim Cramer Discussed These 6 Stocks Recently - Insider Monkey
Wall Street Analysts See a 58.49% Upside in Delcath Systems (DCTH): Can the Stock Really Move This High? - MSN
Delcath Systems to Participate at the Canaccord Genuity Horizons in Oncology Virtual Conference - Lelezard
Liver Cancer Treatment Breakthrough? Delcath to Reveal Latest Advances at Major Oncology Conference - Stock Titan
Is aTyr Pharma (ATYR) Stock Outpacing Its Medical Peers This Year? - Nasdaq
Delcath Systems, Inc. (NASDAQ:DCTH) Q4 2024 Earnings Call Transcript - MSN
Delcath Systems awards stock options to new employees By Investing.com - Investing.com Australia
Delcath Systems awards stock options to new employees - Investing.com India
Delcath Systems Strengthens Workforce: 264,000 Stock Options Granted to New Strategic Hires - StockTitan
Delcath Systems Reports Strong 2024 Financial Growth - TipRanks
With A 27% Price Drop For Delcath Systems, Inc. (NASDAQ:DCTH) You'll Still Get What You Pay For - Simply Wall St
Delcath Systems’ Earnings Call Highlights Strong Growth and Strategic Expansion - TipRanks
HC Wainwright Estimates Delcath Systems FY2029 Earnings - Defense World
Delcath Systems (NASDAQ:DCTH) Price Target Raised to $24.00 - Defense World
Delcath Systems, Inc. (DCTH) Beats Q4 Earnings and Revenue Estimates - MSN
Earnings Beat: Delcath Systems, Inc. (NASDAQ:DCTH) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts - Yahoo Finance
Private Advisor Group LLC Acquires New Position in Delcath Systems, Inc. (NASDAQ:DCTH) - Defense World
Positive Outlook for Delcath Systems: Promising Growth and Strategic Expansion Drive Buy Rating - TipRanks
Delcath stock price target raised to $24 by H.C. Wainwright - Investing.com India
Strong Growth Potential for Delcath Systems: Buy Rating Affirmed with Raised Price Target - TipRanks
Delcath Systems reports net loss of USD 3.4M in Q4 2024 - Medical Buyer
Here's Why We're Not Too Worried About Delcath Systems' (NASDAQ:DCTH) Cash Burn Situation - Yahoo Finance
Delcath Systems Inc (DCTH) Q4 2024 Earnings Call Highlights: Strong HEPZATO Revenue and ... - Yahoo Finance
Delcath Systems Braces for Financial Impact Amid Uncertain Tax Law Changes - TipRanks
BTIG lifts Delcath Systems stock target to $22, maintains buy By Investing.com - Investing.com Canada
BTIG lifts Delcath Systems stock target to $22, maintains buy - Investing.com
Delcath Systems reports Q4 EPS (11c), consensus 1c - TipRanks
Delcath Systems Inc reports results for the quarter ended December 31Earnings Summary - TradingView
DELCATH SYSTEMS, INC. SEC 10-K Report - TradingView
Earnings call transcript: Delcath Systems Q4 2024 results show mixed performance - Investing.com
Delcath Systems Inc (DCTH) Q4 Earnings: Revenue Surpasses Estima - GuruFocus.com
Delcath Systems Inc. Q4 Loss Decreases, But Misses Estimates - Nasdaq
Can Delcath's 30x Revenue Growth and FDA Trial Approval Transform Cancer Treatment? - StockTitan
Delcath Systems, Inc. (NASDAQ:DCTH) Shares Acquired by Principal Financial Group Inc. - Defense World
Carcinoid Tumor Treatment Market Size in the 7MM is expected - openPR
Delcath Systems Inc (DCTH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
7.46%
자본화:
|
볼륨(24시간):